These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 23978486)

  • 1. Allopregnanolone and mood disorders.
    Bäckström T; Bixo M; Johansson M; Nyberg S; Ossewaarde L; Ragagnin G; Savic I; Strömberg J; Timby E; van Broekhoven F; van Wingen G
    Prog Neurobiol; 2014 Feb; 113():88-94. PubMed ID: 23978486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
    Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
    Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.
    Bäckström T; Haage D; Löfgren M; Johansson IM; Strömberg J; Nyberg S; Andréen L; Ossewaarde L; van Wingen GA; Turkmen S; Bengtsson SK
    Neuroscience; 2011 Sep; 191():46-54. PubMed ID: 21600269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
    Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
    J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.
    Bäckström T; Bixo M; Strömberg J
    Curr Psychiatry Rep; 2015 Nov; 17(11):92. PubMed ID: 26396092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
    Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
    Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.
    N-Wihlbäck AC; Sundström-Poromaa I; Bäckström T
    Psychopharmacology (Berl); 2006 Jun; 186(3):388-401. PubMed ID: 16362406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis in menstrual cycle-linked CNS disorders.
    Bäckström T; Andersson A; Andreé L; Birzniece V; Bixo M; Björn I; Haage D; Isaksson M; Johansson IM; Lindblad C; Lundgren P; Nyberg S; Odmark IS; Strömberg J; Sundström-Poromaa I; Turkmen S; Wahlström G; Wang M; Wihlbäck AC; Zhu D; Zingmark E
    Ann N Y Acad Sci; 2003 Dec; 1007():42-53. PubMed ID: 14993039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.
    Andréen L; Sundström-Poromaa I; Bixo M; Andersson A; Nyberg S; Bäckström T
    Psychoneuroendocrinology; 2005 Feb; 30(2):212-24. PubMed ID: 15471618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.
    Kask K; Bäckström T; Lundgren P; Sundström Poromaa I
    Pharmacol Biochem Behav; 2009 Jun; 92(4):608-13. PubMed ID: 19268499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive GABA
    Bäckström T; Das R; Bixo M
    J Neuroendocrinol; 2022 Feb; 34(2):e13013. PubMed ID: 34337790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
    Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
    Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
    Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder.
    Sikes-Keilp C; Rubinow DR
    CNS Drugs; 2023 Aug; 37(8):679-693. PubMed ID: 37542704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.
    Gingnell M; Bannbers E; Wikström J; Fredrikson M; Sundström-Poromaa I
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1474-83. PubMed ID: 24001875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.